| CAS登錄號 | 中文名 | 英文名 | 分子結構式 | 分子式 | 詳情 | 供應商 |
| 92648-68-5 | Acetamide,2-[acetyl[4-(2-propen-1-yloxy)phenyl]amino]-N,N-dimethyl-; Acetanilide,4'-(allyloxy)-N-[(dimethylcarbamoyl)methyl]- (6CI,7CI) |  | C15H20N2O3 | 詳情 | 供應商 | |
| 436086-97-4 | Butanoic acid,4-oxo-4-[[4-(1-piperidinyl)phenyl]amino]-; N-(4-PIPERIDIN-1-YL-PHENYL)-SUCCINAMIC ACID; TIMTEC-BB SBB012189 |  | C15H20N2O3 | 詳情 | 供應商 | |
| 100310-96-1 | Carbamic acid,2-benzofuranyl-, 2-(diethylamino)ethyl ester (9CI) |  | C15H20N2O3 | 詳情 | 供應商 | |
| 302553-78-2 | Carbamic acid,[cis-4-(aminocarbonyl)cyclohexyl]-, phenylmethyl ester (9CI); Carbamic acid, [cis-4-(aminocarbonyl)cyclohexyl]-, phenylmethyl ester (9CI) |  | C15H20N2O3 | 詳情 | 供應商 | |
| 31224-92-7 | Ethanone,2-[4-[1-(hydroxyimino)ethyl]phenoxy]-1-(1-piperidinyl)-; Piperidine,1-[(p-acetylphenoxy)acetyl]-, p-oxime (8CI); Piperidine,1-[[4-[1-(hydroxyimino)ethyl]phenoxy]acetyl]- (9CI); 1-[(p-Acetylphenoxy)acetyl]piperidine p-oxime; 4'-(1-Piperidylcarbonylmethoxy)acetophenone oxime; Pifoxime; Pixifenide |  | C15H20N2O3 | 詳情 | 供應商 | |
| 69382-21-4 | Ethanone,1-[3-(4-morpholinylmethyl)-1H-indol-5-yl]-, hydrate (1:1); Ethanone,1-[3-(4-morpholinylmethyl)-1H-indol-5-yl]-, monohydrate (9CI) |  | C15H20N2O3 | 詳情 | 供應商 | |
| 30000-83-0 | Propanoic acid,3-[[3-[2-(dimethylamino)ethyl]-1H-indol-4-yl]oxy]-; Propionicacid, 3-[[3-[2-(dimethylamino)ethyl]indol-4-yl]oxy]- (8CI) |  | C15H20N2O3 | 詳情 | 供應商 | |
| 349401-48-5 | 1-Piperazineaceticacid, a-oxo-4-(phenylmethyl)-, ethylester; 2-(4-BENZYL-PIPERAZIN-1-YL)-2-OXO-ACETIC ACID ETHYL ESTER; 2-(4-Benzyl-piperazin-1-yl)-2-oxo-acetic acid |  | C15H20N2O3 | 詳情 | 供應商 | |
| 121635-52-7 | 1H-1,5-Benzodiazepine-2-carboxylicacid, 5-acetyl-2,3,4,5-tetrahydro-4-methyl-, ethyl ester |  | C15H20N2O3 | 詳情 | 供應商 | |
| 882029-13-2 | 3-(2-三甲基乙酰氨基-3-吡啶基)丙烯酸乙酯 | 2-Propenoic acid,3-[2-[(2,2-dimethyl-1-oxopropyl)amino]-3-pyridinyl]-, ethyl ester; ETHYL 3-[(2-PIVALOYLAMINO)PYRIDINE-3-YL]ACRYLATE; Ethyl 3-(2-trimethylacetamido-3-pyridyl)acrylate |  | C15H20N2O3 | 詳情 | 供應商 |
| 134721-60-1 | 2,4-Imidazolidinedione,3,5-dimethyl-5-[4-(2-methylpropoxy)phenyl]- |  | C15H20N2O3 | 詳情 | 供應商 | |
| 134721-59-8 | 2,4-Imidazolidinedione,5-(4-butoxyphenyl)-3,5-dimethyl- |  | C15H20N2O3 | 詳情 | 供應商 | |
| 14357-94-9 | 2,4,6(1H,3H,5H)-Pyrimidinetrione,5-(1-cyclohexen-1-yl)-1,5-dimethyl-3-(2-propen-1-yl)-; 2,4,6(1H,3H,5H)-Pyrimidinetrione,5-(1-cyclohexen-1-yl)-3,5-dimethyl-5-(2-propenyl)- (9CI); Barbituric acid,1-allyl-5-(1-cyclohexen-1-yl)-3,5-dimethyl- (8CI); N-Allylhexobarbital |  | C15H20N2O3 | 詳情 | 供應商 | |
| 101496-69-9 | 2,5-Pyrrolidinedione,1-[5-(4-aminophenoxy)pentyl]-; Succinimide,N-[5-(p-aminophenoxy)pentyl]- (6CI) |  | C15H20N2O3 | 詳情 | 供應商 | |
| 145743-47-1 | 3-Pyrazolidinone,5-[3-(cyclopentyloxy)-4-methoxyphenyl]-; 5-[3-(CYCLOPENTYLOXY)-4-METHOXYPHENYL]PYRAZOLIDIN-3-ONE |  | C15H20N2O3 | 詳情 | 供應商 | |
| 68524-21-0 | 2,4-Imidazolidinedione,5-methyl-5-[4-(3-methylbutoxy)phenyl]-; 5-(p-Isoamyloxyphenyl)-5-methylhydantoin |  | C15H20N2O3 | 詳情 | 供應商 | |
| 84990-23-8 | 4H-Indol-4-one,1,5,6,7-tetrahydro-1,3-dimethyl-2-(4-morpholinylcarbonyl)-; Morpholine,4-[(4,5,6,7-tetrahydro-1,3-dimethyl-4-oxo-1H-indol-2-yl)carbonyl]- (9CI); NSC196851 |  | C15H20N2O3 | 詳情 | 供應商 | |
| 655239-35-3 | 7-METHOXY-1-METHYL-D-TRYPTOPHAN ETHYL ESTER |  | C15H20N2O3 | 詳情 | 供應商 | |
| 572923-16-1 | (S)-4-(4-ETHYL-2-OXOOXAZOLIDIN-3-YL)-N-PROPYLBENZAMIDE |  | C15H20N2O3 | 詳情 | 供應商 | |
| 436088-44-7 | N-(2-PIPERIDIN-1-YL-PHENYL)-SUCCINAMIC ACID |  | C15H20N2O3 | 詳情 | 供應商 | |